Promising CRISPR treatment for sickle cell disease
Early results from 10 patients at an American Society of Hematology meeting show people with sickle cell disease and beta thalassemia no longer need regular transfusions and are free from painful crises. Victoria Gray, the first patient, reports dramatic relief after a year. The approach permanently alters DNA in blood cells using CRISPR, aiming to cure these inherited blood disorders.
MENTIONED IN THIS ARTICLE
American Society of Hematology
New England Journal of Medicine
Victoria Gray
First Patient Enters New Sickle Cell Study
Victoria Gray, the first patient in a new sickle cell study, describes lifelong widespread pain and burning sensations across her body as she participates in the trial. Marion Renault reports for the Associated Press.
MENTIONED IN THIS ARTICLE
Victoria Gray
Love of sports drew doctor to field at Baker University
Dr. Emily Heronemus, primary care sports medicine provider for OrthoKansas, discusses her role with Baker University athletes. She evaluates musculoskeletal issues, orders imaging, and collaborates with Baker athletic trainers to keep players healthy and eligible to return to play amid COVID precautions.
MENTIONED IN THIS ARTICLE
Emily Heronemus
OrthoKansas
Stephan Pro
Baker University
Heronemus
Baker
Baker Athletic Department
Also Mentioned on This Page
Gray
Forest
Mississippi
Anthem Pictures
Sarah Cannon Research Institute
Children’s Hospital
TriStar Centennial
Nashville
Janice Haney Carr
CDC and Sickle Cell Foundation of Georgia
Marion Renault
Associated Press
By Jessica Brewer
Fn Lmh Health
Lmh.org
Kansas